About $150 million has been earmarked for clinical trials examining patient-centered outcomes in real world settings. The proposed studies should focus on comparing the relative effectiveness of available resources and interventions to treat a range of health conditions.
The institute is also offering a $25 million grant to support research on the treatment of rare diseases using the National Patient-Centered Clinical Research Network, as well as a $20 million grant to fund studies comparing older and newer medications as second-line treatments for Type 2 diabetes among people with moderate cardiovascular risk.
More articles on clinical leadership and infection control:
North Carolina university to offer master’s degree in patient safety
Judge changes mind, orders release of Seattle Children’s mold records
Patient charged in stabbing of 3 nurses with scissors at New York hospital
